Pomegranate Health: Severe Asthma

For years the management model for asthma has been empirical. The more serious the disease, the more the dose of controller therapy is increased. But this doesn’t work for everyone and a more rational approach involves identifying one of three distinct pathological pathways. 

In this podcast, you will hear from Professor Peter Gibson FRACP and Professor Vanessa McDonald FRCNA, both from the Hunter Medical Research Institute.

They describe emerging diagnostic tools therapies such as monoclonal antibodies that are targeted to specific disease phenotypes. They also discuss the co-morbidities and risk factors that contribute to the disease, and to coordinate therapy in a multi-disciplinary way. The guests for this episode published a Clinical Perspectives review in June’s Internal Medicine Journal.

Listen to ​Severe Asthma podcast episode by downloading or streaming on iTunes or  Android, or listen online.  

Claim CPD credits for listening to Pomegranate through MyCPD.